Abstract:PI3K comprise a group of lipid kinases mainly made up of three classes and have a particular role in signal transduction. The aberration of class IA PI3K is most frequently shown in cancer. The computation techniques have been applied for the identification of potent compounds. This involved the generation of a library of novel compounds (2700) through R-group enumeration study. The screening process utilized a combination of pharmacophore-based virtual screening and various docking algorithms, leading to the discovery of ten novel compounds. The docking studies against PI3K kinase highlighted MSA6 and MSA7 as the most promising compounds, with docking scores of -9.03 and -9.0 kcal/mol, respectively. Results of docking studies of all derivatives confirmed satisfactory binding mode of the compounds within the active site of the target protein PI3K kinase. The screened pyrazolo-pyridine derivatives (MSA1-MSA10) were synthesized and evaluated as anti-cancer agents against NSCLC using A549 cell line. MSA6 showed the dose dependent enhancement in ROS production at concentration of 10 and 20 μM in A549 cells. MSA6 triggered caspase 3 cleavage in lung cancer cells in a dose-dependent manner. MSA6 treatment at 10 and 20 μM levels boosted NF-κβ expression in the cytoplasm while decreasing it in the nucleus, as demonstrated by flow cytometry with an anti-NF-κβ antibody. The modulation of PI3K activity have been observed at 10 μM and 20 μM concentration of MSA6. A549 cells treated with MSA6 with 20 μM showed significant reduction in wound healing in cancerous cell. A549 cells treated with 20 μM showed significantly reduction in number of colonies compared to control group. Compound MSA6 having a methyl group at the para position of phenyl ring at imine carbon and phenyl ring substitution at nitrogen of pyrazole ring exhibited remarkable growth inhibitory activity with IC 50 value of 49.23 μM. Based on the above results, pyrazolo-pyridine derivatives can be used for the further development of novel PI3K kinase inhibitors as anticancer agents.

Total Synthesis of the G2/M DNA Damage Checkpoint Inhibitor Psilostachyin C.

Design, Synthesis and Biological Evaluation of Thienopyridinones As Chk1 Inhibitors

Total Synthesis of Plagiochin G and Derivatives As Potential Cancer Chemopreventive Agents.

A Transition Metal-Free Approach to a Regioselective Total Synthesis of the Natural Product Derivative 6-Methylellipticine, a Potent Anticancer Agent

Total Synthesis of 6-Deoxypladienolide D and Assessment of Splicing Inhibitory Activity in a Mutant SF3B1 Cancer Cell Line

Synthesis, crystal structure, Hirshfeld surface, computational and biological studies of spiro-oxindole derivatives as MDM2-p53 inhibitors

Synthesis-enabled probing of mitosene structural space leads to improved IC₅₀ over mitomycin C.

Synthesis and Biological Evaluation of 2,6-Disubstituted-9h-purine, 2,4-Disubstitued-thieno[3,2-d]pyrimidine and -7H-pyrrolo[2,3-d]pyrimidine Analogues As Novel CHK1 Inhibitors.

Synthesis And In Vitro Cytotoxic Evaluation Of Novel -(3,4,5-Trimethoxyphenyl)Pyridin-2()-One Derivatives

Total synthesis, structure revision and cytotoxic activity of Sch 53825 and its derivatives

Design and Synthesis of Novel α-Methylchalcone Derivatives, Anti-Cervical Cancer Activity, and Reversal of Drug Resistance in HeLa/DDP Cells

Enhanced DNA damage and anti-proliferative activity of a novel ruthenium complex with a chlorambucil-decorated ligand

Synthesis, DNA Intercalation and 3D QSAR Analysis of Cis-2,4,5-trisubstituted-1,3-dithiolanes As a Novel Class of Antitumor Agents.

Synthesis, SAR Study and Biological Evaluation of Novel Pyrazolo[1,5-A]pyrimidin-7-yl Phenyl Amides As Anti-Proliferative Agents

Synthesis of chamaecypanone C analogues from in situ-generated cyclopentadienones and their biological evaluation.

Unified Flexible Total Synthesis of Chlorofusin and Artificial Click Mimics As Antagonists Against P53–hdm2 Interactions

Design, synthesis and biological evaluation of novel pyrrolidone-based derivatives as potent p53-MDM2 inhibitors

Synthesis and Biological Evaluation of Cardiac Glycosides for Cancer Therapy by Targeting the DNA Damage Response

Design and synthesis of novel imidazole-chalcone derivatives as microtubule protein polymerization inhibitors to treat cervical cancer and reverse cisplatin resistance

Discovery of Pyrimidine-Bridged CA-4 CBSIs for the Treatment of Cervical Cancer in Combination with Cisplatin with Significantly Reduced Nephrotoxicity.

Combined computational and synthetic strategies for the development of potent pyrazolo-pyridine derivatives as anticancer agents